Boehringer Ingelheim Pharma Gmbh And Co. Kg & Anr. v. Vee Excel Drugs and Pharmaceuticals Private Ltd. & Ors., Alkem Laboratories Ltd & Anr., Micro Labs Limited, Natco Pharma Limited & Anr., Mankind Pharma Limited

2023:DHC:2268 (CS(COMM) 239/2019 & connected matters)

Boehringer Ingelheim Pharma sought permanent injunctions against various Indian pharmaceutical companies, alleging infringement of Patent No. IN 243301 related to Linagliptin tablets. The Delhi High Court examined the applications for interim injunction across multiple connected suits. The court found that the plaintiffs failed to establish a prima facie case, noting concerns about potential patent vulnerability due to prior claiming and attempts at evergreening. Consequently, all interim injunction applications were dismissed, allowing defendants to continue manufacturing and selling the products.

Jurisdiction
India
Court
Delhi High Court
Case Number
2023:DHC:2268 (CS(COMM) 239/2019 & connected matters)
Judge(s)
Amit Bansal

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court. Understanding the court's reasoning in Boehringer Ingelheim Pharma Gmbh And Co. Kg & Anr. vs Vee Excel Drugs and Pharmaceuticals Private Ltd. & Ors., Alkem Laboratories Ltd & Anr., Micro Labs Limited, Natco Pharma Limited & Anr., Mankind Pharma Limited is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentCIVIL MISCELLANEOUS APPEAL NOS. 180, 181 AND 182 OF 2020

Ms Industries And Spirits P LtdvsM/S. Allied Blenders And Distillers Pvt ...

This appeal challenged the orders passed by the City Civil Court that granted an ex parte ad interim injunction in a suit concerning alleged trademark and copyright infringement. The plaintiff claimed their 'Officer's Choice' brand was being copied by the defendant's 'Manjeera Classic No.1 Whisky'. However, the Telangana High Court set aside these initial injunction orders, finding that the lower court failed to provide adequate reasons for granting the ex parte relief as mandated by law. Consequently, the matter was remanded back to the trial court for a fresh and balanced adjudication.

patentCS(COMM) 381/2023, I.A. 10912/2023, I.A. 10913/2023

Hindware LimitedvsAnil Kumar & Ors.

In a significant development concerning trademark infringement, Hindware Limited successfully negotiated an amicable settlement with Defendant No. 1. The plaintiff agreed to drop its claim for damages provided that the defendant withdraws his pending trademark application and commits not to use the disputed mark 'HINDWARE' on his goods. This order marks a pragmatic resolution in the ongoing dispute.

patentC.A.(COMM.IPD-PAT) 6/2023 & I.A. 10451/2024

CellectisvsThe Assistant Controller Of Patents And Designs

Cellectis appealed a refusal order by the Controller of Patents regarding its patent application for a method involving T-Cells. The appeal sought permission to file amended claims and complete specification. The court examined whether these amendments were permissible under Section 59 of the Patents Act.

patentWP(C) NO. 40562 OF 2025

Royal Coffee WorksvsThe Registrar Of Trademarks; Girnar Food & Beverages Pvt. Limited

Royal Coffee Works challenged the delay in processing its trademark application before the Registrar of Trademarks, which was opposed by Girnar Food & Beverages Pvt. Limited regarding the use of 'tea' in the product description. The Kerala High Court addressed the petitioner's grievance concerning procedural delays. The court directed the Registrar to expedite the matter and pass appropriate orders on both the original trademark application and the opposition within a three-month timeframe.

patentCS(COMM) 1363/2025

Kenvue Brands Llc & AnrvsRspl Limited

Plaintiffs filed a suit seeking permanent injunction against infringement of their patent (IN 339964) by Defendant's products. The court, while considering an application for interim injunction, raised serious doubts regarding the authenticity and timing of the technical expert affidavit provided by the Plaintiffs.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call